Calidi Biotherapeutics, Inc. (CLDI)

USD 0.42

(-15.14%)

Total Assets Summary of Calidi Biotherapeutics, Inc.

  • Calidi Biotherapeutics, Inc.'s latest annual total assets in 2023 was 10.01 Million USD , up 285.79% from previous year.
  • Calidi Biotherapeutics, Inc.'s latest quarterly total assets in 2024 Q2 was 6.43 Million USD , down -13.15% from previous quarter.
  • Calidi Biotherapeutics, Inc. reported annual total assets of 2.59 Million USD in 2022, down -98.88% from previous year.
  • Calidi Biotherapeutics, Inc. reported annual total assets of 231.76 Million USD in 2021, up 12414.54% from previous year.
  • Calidi Biotherapeutics, Inc. reported quarterly total assets of 7.4 Million USD for 2024 Q1, down -26.09% from previous quarter.
  • Calidi Biotherapeutics, Inc. reported quarterly total assets of 10.01 Million USD for 2023 Q4, down -46.1% from previous quarter.

Annual Total Assets Chart of Calidi Biotherapeutics, Inc. (2023 - 2020)

Historical Annual Total Assets of Calidi Biotherapeutics, Inc. (2023 - 2020)

Year Total Assets Total Assets Growth
2023 10.01 Million USD 285.79%
2022 2.59 Million USD -98.88%
2021 231.76 Million USD 12414.54%
2020 1.85 Million USD 0.0%

Peer Total Assets Comparison of Calidi Biotherapeutics, Inc.

Name Total Assets Total Assets Difference
AIM ImmunoTech Inc. 19.38 Million USD 48.305%
Ampio Pharmaceuticals, Inc. 5.73 Million USD -74.669%
Armata Pharmaceuticals, Inc. 109.96 Million USD 90.889%
Actinium Pharmaceuticals, Inc. 81.44 Million USD 87.698%
Azitra, Inc. 5.11 Million USD -95.856%
Can-Fite BioPharma Ltd. 9.98 Million USD -0.3%
Chromocell Therapeutics Corporation 96.39 Thousand USD -10294.124%
CEL-SCI Corporation 30.52 Million USD 67.181%
iBio, Inc. 28.73 Million USD 65.132%
Lineage Cell Therapeutics, Inc. 101.01 Million USD 90.082%
MAIA Biotechnology, Inc. 7.56 Million USD -32.406%
Matinas BioPharma Holdings, Inc. 65.57 Million USD 84.722%
Navidea Biopharmaceuticals, Inc. 4.37 Million USD -129.184%
NovaBay Pharmaceuticals, Inc. 9.03 Million USD -10.903%
NanoViricides, Inc. 12.82 Million USD 21.866%
Oragenics, Inc. 4.96 Million USD -101.738%
BiomX Inc. 58.15 Million USD 82.772%
BiomX Inc. 58.15 Million USD 82.772%
Protalix BioTherapeutics, Inc. 84.43 Million USD 88.134%
Palatin Technologies, Inc. 10.74 Million USD 6.733%
Scorpius Holdings, Inc. 51.03 Million USD 80.369%
Theriva Biologics, Inc. 60.21 Million USD 83.36%